Drugs / HRS-8797
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07698756 | Jul → Dec 2026 expected | atopic eczema | Chengdu Suncadia Medicine Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRS-8797 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07698756 ↗ |
| Route | Oral | “Following Single and Multiple Oral Doses” NCT07698756 ↗ |